The life sciences encompass research fields that have a direct impact on our quality of our health, food and environment including pharmaceuticals, genetics, systems biology and biotechnology. Now, in the post-genomic era, the domain has undergone a revolution in terms of research approaches, new infrastructure needs and technology developments and, now more than ever, we are witnessing new developments which directly impact on our lives.
These developments are taking place throughout the world and, in order for Europe to remain competitive with the US and Asia, the necessary critical mass of expertise and resources must be made available in a coordinated manner. Currently, R & D investment is fragmented among numerous funding bodies across Europe. Now, with support from the European Commission, the ESF will launch this unique initiative to bring together these funding bodies and life sciences researchers to develop a more coordinated strategy for planning and investing in life sciences research. The establishment of EuroBioFund is well timed given that the EU’s New Seventh Framework Programme (FP7), will be launched officially as of January 1 2007, with a budget of €50 billion to invest in scientific research and innovation.
The three key objectives of the EuroBioFund are:
1. Provide a platform for funding organisations and life science researchers to foster joint research initiatives through networking and brokerage: EuroBioForum
2. Help organise research communities and facilitate bottom-up generation of research programmes of European scale and scope: EuroBioGenerator
3. Shape a new funding way in Europe by helping to develop joint investments and funding of life sciences research: EuroBioAccess
EuroBioFund’s new approach will centre on an annual conference, EuroBioForum, and the first will be held in Helsinki 14-15 December 2006. For funders this is a unique opportunity to engage with key life science research groups presenting proposals for cutting-edge pan-European research programmes. From the researcher’s side, EuroBioForum provides a forum to promote important research topics to those funding and investing in life sciences R & D.
‘Moving toward a more coordinated approach to R & D investment in the life sciences is a challenging but necessary step if Europe is to remain an important global player in life sciences and biotechnology research,’ says Wouter Spek, Director of EuroBioFund.
Wouter Spek | alfa
Molecular doorstop could be key to new tuberculosis drugs
20.03.2018 | Rockefeller University
Modified biomaterials self-assemble on temperature cues
20.03.2018 | Duke University
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
20.03.2018 | Physics and Astronomy
20.03.2018 | Physics and Astronomy
20.03.2018 | Earth Sciences